Respiratory Weekly News - June 6th 2025
Lung & Respiratory Breakthroughs: STAT6 Degraders, IPF Cough Relief, and…
Respiratory Weekly News - May 30th 2025
Lung & Respiratory Research Breakthroughs: Biologic Approvals, Dual-Target…
Artificial Intelligence and Digital Health Weekly News - May 26th 2025
🤖 Artificial Intelligence and Digital Health Update: WHO Strategy, Cancer…
Respiratory Weekly News - May 23rd 2025
Lung & Respiratory Breakthroughs: IPF Therapies, Asthma Innovations, COPD…
ATS 2025 Preview: Key Respiratory Highlights To Watch
ATS 2025 at a glance Prepare for ATS 2025 with LucidQuest’s concise preview,…
Respiratory Weekly News - May 16th 2025
Lung & Respiratory Health Breakthroughs: IPF Patient Voices, Asthma Trial…
Respiratory Weekly News - May 9th 2025
Lung & Respiratory Health Breakthroughs: Nucala COPD Data, Breztri Asthma…
Respiratory Weekly News - May 2nd 2025
Lung & Respiratory Health Updates: CF Drug Approvals, RSV Breakthroughs,…
Respiratory Weekly News - 25th April 2025
Lung & Respiratory Breakthroughs: Trelegy Data, EGPA Drug Status,…
Respiratory Weekly News - 18th April 2025
Lung & Respiratory Updates: Fibrosis, COPD, Asthma & More …
Respiratory Weekly News - April 11th 2025
What’s New in Respiratory Space This Week Catch the latest lung and…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches.
The challenge: How to prepare when two new competitors enter your space Α…